Androgen Mediation-and Antiandrogens Mitigation-of the Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash: Results From a Pilot Randomized Trial and Small Translational Case Series.

CONCLUSIONS:: Epidermal growth factor receptor inhibitor-induced rash appears to be androgen-mediated; antiandrogen therapy merits further study for rash prevention/palliation. PMID: 30602311 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30602311?dopt=Abstract

Source: The American Journal of Hospice and Palliative Care - January 2, 2019 Category: Palliative Care Authors: Le-Rademacher JG, Rowland K, Atherton PJ, Dakhil C, Sun Z, Tan A, Schmidt L, Nguyen PL, Radecki Breitkopf C, Pittelkow M, Tindall D, Menon S, Jatoi A Tags: Am J Hosp Palliat Care Source Type: research